Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | April 28, 2017 | May 02, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date April 28, 2017 · Filed May 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 51,241 |
Reported balance
After 2017-04-28 transaction · row 1
1 source rowRow 1 · 2017-04-28 · Tax withholding · Acquired 189 · Balance 51,241 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2017 Filed May 2, 2017 21:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 189 | $43.65 | $8,249.85 |
DisclosureSEC source: 0001179110-17-006400 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,241 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 22:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,601 | $45.39 | $72,669.39 |
DisclosureSEC source: 0001179110-17-003681 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,430 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,302 | $45.46 | $195,568.92 |
DisclosureSEC source: 0001179110-17-003681 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,031 Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 22:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 319 | $44.98 | $14,348.94 |
DisclosureSEC source: 0001179110-17-002931 · edgar.xml · nonDerivative · entry 3 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,333 Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 22:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 819 | $44.69 | $36,601.11 |
DisclosureSEC source: 0001179110-17-002931 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,652 Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 22:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 76,693 | $0.00 Strike: $44.40 | $0.00 |
DisclosureSEC source: 0001179110-17-002931 · edgar.xml · derivative · entry 4 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,693 Underlying: Common shares · 76,693 shares Expires 2027-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 25,565 on 2/17/2018, 25,564 on 2/17/2019, and 25,564 on 2/17/2020. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 22:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 11,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002931 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,471 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| April 28, 2016 Filed Apr 29, 2016 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 53 | $41.31 | $2,189.43 |
DisclosureSEC source: 0001179110-16-023446 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,382 Read SEC document |
| April 28, 2016 Filed Apr 29, 2016 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 136 | $43.83 | $5,960.88 |
DisclosureSEC source: 0001179110-16-023446 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,435 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $39.28 | $3,927.50 |
DisclosureSEC source: 0001179110-16-020739 · edgar.xml · nonDerivative · entry 3 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,571 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 693 | $39.27 | $27,214.80 |
DisclosureSEC source: 0001179110-16-020739 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,671 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,040 | $39.52 | $80,620.80 |
DisclosureSEC source: 0001179110-16-020739 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,364 Read SEC document |
| February 22, 2016 Filed Feb 23, 2016 22:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $39.10 | $11,728.50 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · nonDerivative · entry 4 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,404 Read SEC document |
| February 22, 2016 Filed Feb 23, 2016 22:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 19 | $39.09 | $742.79 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · nonDerivative · entry 3 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,704 Read SEC document |
| February 21, 2016 Filed Feb 23, 2016 22:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 819 | $38.53 | $31,556.07 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,723 Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 145,547 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · derivative · entry 5 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,547 Underlying: Common shares · 145,547 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 48,516 on 02/19/2017, 48,515 on 02/19/2018, and 48,516 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 16,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,542 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2016 Filed Feb 17, 2016 22:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 171 | $37.13 | $6,349.23 |
DisclosureSEC source: 0001179110-16-019503 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,941 Read SEC document |
| February 15, 2016 Filed Feb 17, 2016 22:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 501 | $37.13 | $18,602.13 |
DisclosureSEC source: 0001179110-16-019503 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,112 Read SEC document |
| April 28, 2015 Filed Apr 29, 2015 22:22 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 144 | $47.49 | $6,838.56 |
DisclosureSEC source: 0001179110-15-006829 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,613 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.